Literature DB >> 21767110

Optimal HAART adherence over time and time interval between successive visits: their association and determinants.

Dikokole Maqutu1, Temesgen Zewotir.   

Abstract

We aimed to investigate the determinants of optimal highly active antiretroviral therapy (HAART) adherence and time interval between successive clinic visits, and the association between these two processes. This was done by reviewing routinely collected patient information in the Centre for the AIDS Programme of Research in South Africa (CAPRISA). Records of 688 patients enrolled in the CAPRISA AIDS treatment (CAT) programme between 2004 and 2006 were analysed. Patients were considered adherent if they had taken at least 95% of their prescribed drugs. The adherence has been measured using the pill counts data. A multivariate generalised mixed random effects approach was used to jointly analyse optimal HAART adherence and time interval between successive visits. The results showed that on the overall, the association between optimal HAART adherence and time interval between successive visits was negative. The results further showed that the interaction between time and treatment site had a significant joint effect on optimal HAART adherence and time interval between successive visits. The interaction revealed that as the number of follow-up visits increased, the interval between successive visits also increased while at the same time high levels of optimal adherence were maintained in the rural treatment site. Moreover, after accounting for the time interval between successive visits, the results showed that optimal HAART adherence was significantly associated with having a cell phone, living with a partner as well as interactions that include time and gender, time and treatment site, age and gender and age and education. The findings provide evidence of a negative association between optimal HAART adherence and the time interval between successive clinic visits on the overall, which therefore indicates that longer time interval between successive clinic visits is undesirable if optimal HAART adherence is to be maintained. This notwithstanding, rural patients were able to maintain HAART adherence for longer time interval between successive clinic visits. Furthermore, the findings indicated that optimal HAART adherence was low for some sub-populations, such as the urban and male populations, thus vigorous ongoing adherence counseling is required.

Entities:  

Mesh:

Year:  2011        PMID: 21767110      PMCID: PMC3630300          DOI: 10.1080/09540121.2011.565028

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  19 in total

1.  Determinants of optimal adherence over time to antiretroviral therapy amongst HIV positive adults in South Africa: a longitudinal study.

Authors:  Dikokole Maqutu; Temesgen Zewotir; Delia North; Kogieleum Naidoo; Anneke Grobler
Journal:  AIDS Behav       Date:  2011-10

2.  Long-term trends in adherence to antiretroviral therapy from start of HAART.

Authors:  Valentina Cambiano; Fiona C Lampe; Alison J Rodger; Colette J Smith; Anna M Geretti; Rebecca K Lodwick; Dewi I Puradiredja; Margaret Johnson; Leonie Swaden; Andrew N Phillips
Journal:  AIDS       Date:  2010-05-15       Impact factor: 4.177

3.  Provider assessment of adherence to HIV antiretroviral therapy.

Authors:  D R Bangsberg; F M Hecht; H Clague; E D Charlebois; D Ciccarone; M Chesney; A Moss
Journal:  J Acquir Immune Defic Syndr       Date:  2001-04-15       Impact factor: 3.731

4.  Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre.

Authors:  A Mocroft; M Youle; A Moore; C A Sabin; S Madge; A C Lepri; M Tyrer; C Chaloner; D Wilson; C Loveday; M A Johnson; A N Phillips
Journal:  AIDS       Date:  2001-01-26       Impact factor: 4.177

5.  Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.

Authors:  Jean B Nachega; Michael Hislop; David W Dowdy; Richard E Chaisson; Leon Regensberg; Gary Maartens
Journal:  Ann Intern Med       Date:  2007-04-17       Impact factor: 25.391

6.  Gender differences in factors associated with adherence to antiretroviral therapy.

Authors:  Karina M Berg; Penelope A Demas; Andrea A Howard; Ellie E Schoenbaum; Marc N Gourevitch; Julia H Arnsten
Journal:  J Gen Intern Med       Date:  2004-11       Impact factor: 5.128

7.  Factors affecting first-month adherence to antiretroviral therapy among HIV-positive adults in South Africa.

Authors:  Dikokole Maqutu; Temesgen Zewotir; Delia North; Kogieleum Naidoo; Anneke Grobler
Journal:  Afr J AIDS Res       Date:  2010-09-22       Impact factor: 1.300

8.  Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy.

Authors:  J Byakika-Tusiime; J H Oyugi; W A Tumwikirize; E T Katabira; P N Mugyenyi; D R Bangsberg
Journal:  Int J STD AIDS       Date:  2005-01       Impact factor: 1.359

9.  Evaluation of the consistency of refills for antiretroviral medications in two hospitals in the state of Rio de Janeiro, Brazil.

Authors:  N Seguy; T Diaz; D Pereira Campos; V G Veloso; B Grinsztejin; L Teixeira; J H Pillotto
Journal:  AIDS Care       Date:  2007-05

10.  Agreement between physicians and non-physician clinicians in starting antiretroviral therapy in rural Uganda.

Authors:  Ashwin Vasan; Nathan Kenya-Mugisha; Kwonjune J Seung; Marion Achieng; Patrick Banura; Frank Lule; Megan Beems; Jim Todd; Elizabeth Madraa
Journal:  Hum Resour Health       Date:  2009-08-20
View more
  7 in total

1.  Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count.

Authors:  Jean Joel R Bigna; Claudia S Plottel; Sinata Koulla-Shiro
Journal:  Infect Dis Poverty       Date:  2016-09-05       Impact factor: 4.520

2.  Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa: a systematic review.

Authors:  Tessa Heestermans; Joyce L Browne; Susan C Aitken; Sigrid C Vervoort; Kerstin Klipstein-Grobusch
Journal:  BMJ Glob Health       Date:  2016-12-30

3.  Joint longitudinal data analysis in detecting determinants of CD4 cell count change and adherence to highly active antiretroviral therapy at Felege Hiwot Teaching and Specialized Hospital, North-west Ethiopia (Amhara Region).

Authors:  Awoke Seyoum; Principal Ndlovu; Zewotir Temesgen
Journal:  AIDS Res Ther       Date:  2017-03-16       Impact factor: 2.250

4.  Predictors of non-adherence to medication and time to default from treatment on HIV infected patients under HAART: a comparison of joint and separate models.

Authors:  Koyachew Bitew Abebe; Awoke Seyoum Tegegne
Journal:  Afr Health Sci       Date:  2022-03       Impact factor: 1.108

5.  Socio-Demographic, Economic and Clinical Predictors for HAART Adherence Competence in HIV-Positive Adults at Felege Hiwot Teaching and Specialized Hospital, North West Ethiopia.

Authors:  Awoke Seyoum Tegegne
Journal:  HIV AIDS (Auckl)       Date:  2021-07-09

6.  Evidence of reduced treatment adherence among HIV infected paediatric and adolescent populations in Nairobi at the onset of the UNAIDS Universal Test and Treat Program.

Authors:  Joseph Kabogo; Erastus Muniu; Fred Wamunyokoli; Rachel Musoke; Elijah Songok
Journal:  BMC Res Notes       Date:  2018-02-17

7.  Association between HIV stigma and antiretroviral therapy adherence among adults living with HIV: baseline findings from the HPTN 071 (PopART) trial in Zambia and South Africa.

Authors:  Harriet S Jones; Sian Floyd; Anne Stangl; Virginia Bond; Graeme Hoddinott; Triantafyllos Pliakas; Justin Bwalya; Nomtha Mandla; Ayana Moore; Deborah Donnell; Peter Bock; Sarah Fidler; Richard Hayes; Helen Ayles; James R Hargreaves
Journal:  Trop Med Int Health       Date:  2020-08-26       Impact factor: 2.622

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.